Logo image of EYE

NATIONAL VISION HOLDINGS INC (EYE) Stock Fundamental Analysis

USA - NASDAQ:EYE - US63845R1077 - Common Stock

26.88 USD
-0.02 (-0.07%)
Last: 10/15/2025, 11:27:46 AM
Fundamental Rating

3

Taking everything into account, EYE scores 3 out of 10 in our fundamental rating. EYE was compared to 120 industry peers in the Specialty Retail industry. While EYE is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, EYE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EYE had positive earnings in the past year.
In the past year EYE had a positive cash flow from operations.
In multiple years EYE reported negative net income over the last 5 years.
Each year in the past 5 years EYE had a positive operating cash flow.
EYE Yearly Net Income VS EBIT VS OCF VS FCFEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

EYE has a Return On Assets (-0.72%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -1.66%, EYE is in line with its industry, outperforming 52.50% of the companies in the same industry.
EYE has a Return On Invested Capital (2.65%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for EYE is significantly below the industry average of 12.17%.
The 3 year average ROIC (1.97%) for EYE is below the current ROIC(2.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROIC 2.65%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
EYE Yearly ROA, ROE, ROICEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Operating Margin, with a value of 2.76%, EYE is in line with its industry, outperforming 52.50% of the companies in the same industry.
In the last couple of years the Operating Margin of EYE has declined.
EYE's Gross Margin of 58.61% is amongst the best of the industry. EYE outperforms 86.67% of its industry peers.
In the last couple of years the Gross Margin of EYE has grown nicely.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 58.61%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
EYE Yearly Profit, Operating, Gross MarginsEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EYE is destroying value.
EYE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EYE has been reduced compared to 5 years ago.
The debt/assets ratio for EYE has been reduced compared to a year ago.
EYE Yearly Shares OutstandingEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EYE Yearly Total Debt VS Total AssetsEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

EYE has an Altman-Z score of 2.24. This is not the best score and indicates that EYE is in the grey zone with still only limited risk for bankruptcy at the moment.
EYE's Altman-Z score of 2.24 is in line compared to the rest of the industry. EYE outperforms 49.17% of its industry peers.
The Debt to FCF ratio of EYE is 4.80, which is a neutral value as it means it would take EYE, 4.80 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.80, EYE is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
EYE has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, EYE is in line with its industry, outperforming 59.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Altman-Z 2.24
ROIC/WACC0.29
WACC9.02%
EYE Yearly LT Debt VS Equity VS FCFEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.52 indicates that EYE may have some problems paying its short term obligations.
EYE has a worse Current ratio (0.52) than 92.50% of its industry peers.
EYE has a Quick Ratio of 0.52. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EYE (0.31) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.31
EYE Yearly Current Assets VS Current LiabilitesEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

EYE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
Measured over the past years, EYE shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.68% on average per year.
EYE shows a decrease in Revenue. In the last year, the revenue decreased by -4.45%.
The Revenue has been growing slightly by 1.12% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%

3.2 Future

EYE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.75% yearly.
Based on estimates for the next years, EYE will show a small growth in Revenue. The Revenue will grow by 5.71% on average per year.
EPS Next Y26.89%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EYE Yearly Revenue VS EstimatesEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
EYE Yearly EPS VS EstimatesEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.80, the valuation of EYE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of EYE is on the same level as its industry peers.
EYE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.49.
EYE is valuated quite expensively with a Price/Forward Earnings ratio of 32.15.
The rest of the industry has a similar Price/Forward Earnings ratio as EYE.
EYE is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.8
Fwd PE 32.15
EYE Price Earnings VS Forward Price EarningsEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

EYE's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EYE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.52
EV/EBITDA 16.74
EYE Per share dataEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as EYE's earnings are expected to grow with 21.75% in the coming years.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y23.3%
EPS Next 3Y21.75%

0

5. Dividend

5.1 Amount

No dividends for EYE!.
Industry RankSector Rank
Dividend Yield N/A

NATIONAL VISION HOLDINGS INC

NASDAQ:EYE (10/15/2025, 11:27:46 AM)

26.88

-0.02 (-0.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners108.99%
Inst Owner Change-0.03%
Ins Owners1.95%
Ins Owner Change5.42%
Market Cap2.13B
Analysts81.33
Price Target29.43 (9.49%)
Short Float %12.01%
Short Ratio4.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.89%
Min EPS beat(2)9.52%
Max EPS beat(2)30.26%
EPS beat(4)4
Avg EPS beat(4)34.01%
Min EPS beat(4)9.52%
Max EPS beat(4)83.55%
EPS beat(8)8
Avg EPS beat(8)45.05%
EPS beat(12)11
Avg EPS beat(12)16.75%
EPS beat(16)15
Avg EPS beat(16)81.36%
Revenue beat(2)2
Avg Revenue beat(2)1.45%
Min Revenue beat(2)0.41%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)8
Avg Revenue beat(16)-0.24%
PT rev (1m)0%
PT rev (3m)46.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.55%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)7.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 44.8
Fwd PE 32.15
P/S 1.13
P/FCF 37.52
P/OCF 14.71
P/B 2.5
P/tB N/A
EV/EBITDA 16.74
EPS(TTM)0.6
EY2.23%
EPS(NY)0.84
Fwd EY3.11%
FCF(TTM)0.72
FCFY2.67%
OCF(TTM)1.83
OCFY6.8%
SpS23.81
BVpS10.74
TBVpS-1.21
PEG (NY)1.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROCE 3.36%
ROIC 2.65%
ROICexc 2.74%
ROICexgc 7.41%
OM 2.76%
PM (TTM) N/A
GM 58.61%
FCFM 3.01%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
ROICexc(3y)2.16%
ROICexc(5y)4.2%
ROICexgc(3y)5.73%
ROICexgc(5y)11.7%
ROCE(3y)2.5%
ROCE(5y)4.55%
ROICexcg growth 3Y-36.81%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-36.88%
ROICexc growth 5Y-10.66%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
F-Score6
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Debt/EBITDA 1.82
Cap/Depr 99.27%
Cap/Sales 4.66%
Interest Coverage 2.69
Cash Conversion 102.87%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.31
Altman-Z 2.24
F-Score6
WACC9.02%
ROIC/WACC0.29
Cap/Depr(3y)109.9%
Cap/Depr(5y)102.38%
Cap/Sales(3y)5.81%
Cap/Sales(5y)5.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
EPS Next Y26.89%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A
EBIT growth 1Y58.39%
EBIT growth 3Y-39.25%
EBIT growth 5Y-13.48%
EBIT Next Year203.78%
EBIT Next 3Y52.22%
EBIT Next 5YN/A
FCF growth 1Y80.13%
FCF growth 3Y-38.43%
FCF growth 5Y-9.78%
OCF growth 1Y0.91%
OCF growth 3Y-19.78%
OCF growth 5Y-4.14%